What's more, it addresses the FDA’s communications Together with the applicant, the retention of documents that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of an SE report to a new applicant and Digital submission on the SE report a